NA
OMCL icon

Navellier & Associates’s Omnicell OMCL Stock Holding History

Navellier & Associates’s Portfolio OMCL Stock Details OMCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-45,000
Closed -$5.83M – 317
2022
Q1 		$5.83M Sell
45,000
-3,253
-7% -$469K 0.99% 23
2021
Q4 		$8.71M Sell
48,253
-1,854
-4% -$322K 1.27% 16
2021
Q3 		$7.44M Buy
+50,107
New +$7.68M 1.12% 20

Other funds holding OMCL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Navellier & Associates's OMCL Position: Q2 2022 in Review

Navellier & Associates sold out of Omnicell (OMCL) in Q2 2022, closing a stake of 45,000 shares — an estimated $5.83M sold.

Navellier & Associates first reported a position in OMCL in Q3 2021 and held it in 3 quarters. The position peaked at $8.71M in Q4 2021. 385 funds tracked by Wall St. Rank hold OMCL as of Q2 2022.

  • Navellier & Associates reported no remaining Omnicell position as of Q2 2022 after selling out during the quarter.
  • Navellier & Associates sold 45,000 Omnicell shares in Q2 2022, an estimated $5.83M.
  • Navellier & Associates first reported a position in Omnicell in Q3 2021 and held it in 3 quarters.
  • Navellier & Associates's Omnicell position peaked at $8.71M in Q4 2021.
  • 385 funds tracked by Wall St. Rank held Omnicell as of Q2 2022.

Based on Navellier & Associates's 13F filing for Q2 2022, filed 12 Aug 2022.